247 related articles for article (PubMed ID: 28423529)
21. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
[TBL] [Abstract][Full Text] [Related]
22. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
Castelo-Branco G; Stridh P; Guerreiro-Cacais AO; Adzemovic MZ; Falcão AM; Marta M; Berglund R; Gillett A; Hamza KH; Lassmann H; Hermanson O; Jagodic M
Neurobiol Dis; 2014 Nov; 71():220-33. PubMed ID: 25149263
[TBL] [Abstract][Full Text] [Related]
23. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
24. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
[TBL] [Abstract][Full Text] [Related]
25. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
26. PreImplantation factor prevents atherosclerosis via its immunomodulatory effects without affecting serum lipids.
Chen YC; Rivera J; Fitzgerald M; Hausding C; Ying YL; Wang X; Todorova K; Hayrabedyan S; Barnea ER; Peter K
Thromb Haemost; 2016 May; 115(5):1010-24. PubMed ID: 26842698
[TBL] [Abstract][Full Text] [Related]
27. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
28. Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
Ozgun-Acar O; Celik-Turgut G; Gazioglu I; Kolak U; Ozbal S; Ergur BU; Arslan S; Sen A; Topcu G
J Neuroimmunol; 2016 Sep; 298():106-16. PubMed ID: 27609283
[TBL] [Abstract][Full Text] [Related]
29. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
31. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
33. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model).
Azar Y; Shainer R; Almogi-Hazan O; Bringer R; Compton SR; Paidas MJ; Barnea ER; Or R
Biol Blood Marrow Transplant; 2013 Apr; 19(4):519-28. PubMed ID: 23266739
[TBL] [Abstract][Full Text] [Related]
34. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
[TBL] [Abstract][Full Text] [Related]
36. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
37. IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.
Kocur M; Schneider R; Pulm AK; Bauer J; Kropp S; Gliem M; Ingwersen J; Goebels N; Alferink J; Prozorovski T; Aktas O; Scheu S
Acta Neuropathol Commun; 2015 Apr; 3():20. PubMed ID: 25853624
[TBL] [Abstract][Full Text] [Related]
38. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
39. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
